MPL and autoimmune thrombocytopenic purpura: Herein, we have applied in silico systems biology and structural-based approaches with the aim of exploring eltrombopag’s off-target effects (understood as MPL-mediated effects on non-megakaryocyte cells or mechanisms that are MPL-independent) that could explain novel ITP immune-related pathophysiological pathways.